Latest news
US FDA to hold advisory meeting to review Grail’s multi-cancer test - 1450 AM 99.7 FM WHTC1450 AM 99.7 FM WHTC · Fri, 07 Aug 2026 21:41:08 GMTLucid Diagnostics Secures Commercial Coverage Policy for Its Esophageal DNA Test - Clinical Lab ProductsClinical Lab Products · Fri, 07 Aug 2026 12:20:13 GMTLucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - MorningstarMorningstar · Wed, 05 Aug 2026 17:46:00 GMTLucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria - Stock TitanStock Titan · Wed, 05 Aug 2026 12:46:00 GMTPacific Edge Advances Urine-Based Bladder Cancer Testing With Medicare Coverage Milestone Ahead of August 2026 Shareholder Meeting - KalkineKalkine · Mon, 27 Jul 2026 07:00:00 GMT